Healthy elderly patients with hardened arteries were up to four times more likely to have amyloid plaque in the brain, according to research published Oct. 16 in Neurology.

Dose-intensification of systemic cancer therapy with I-131 metaiodobenzylguanidine (I-131 MIBG) may be ideal for palliative treatment of neuroendocrine tumors, according to a study published Oct. 7 in the Journal of Nuclear Medicine.

North American Spine Society (NASS) adds advanced medical imaging for some back pain to list of questionable procedures kept by the American Board of Internal Medicine (ABIM) Choosing Wisely initiative

Recognizing that one of the obstacles to getting x-ray access to patients in developing nations is simply knowledge, the Rotary Club of Park Ridge, Ill, has put the information and experience it has gathered installing x-ray rooms in Africa, Central Europe, Latin America and the Caribbean online in a free library resource

There is growing interest in applying molecular imaging techniques for the detection of peripheral vascular disease (PVD). A range of scanner-tracer combinations can be used for perfusion, angiogenesis and atherosclerotic imaging, according to a review published online Oct. 7 in the Journal of Nuclear Medicine.

An estimated 30 percent of epileptics experience drug resistance. A PET agent may one day be used to track physiological mechanisms of resistance, according to a study published online Oct. 3 in the Journal of Nuclear Medicine.

A novel cannabinoid type 2 receptor ligand that binds to microglial and immuno cells could be a hit for neuro-inflammatory imaging, according to a study published in the August 2013 issue of Molecular Imaging and Biology.

This week, Oct. 6-12, is Nuclear Medicine and Molecular Imaging Week and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the SNMMI Technologist Section (SNMMI-TS) are rallying the medical community to raise public awareness about the industry.